BDZ-g

CAS No. 732278-52-3

BDZ-g( —— )

Catalog No. M35613 CAS No. 732278-52-3

BDZ-g is a potent and selective antagonist of AMPA receptor. BDZ-g can be used for the research of various neurological disorders involving excessive activity of AMPA receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 117 In Stock
5MG 107 In Stock
10MG 157 In Stock
25MG 236 In Stock
50MG 324 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BDZ-g
  • Note
    Research use only, not for human use.
  • Brief Description
    BDZ-g is a potent and selective antagonist of AMPA receptor. BDZ-g can be used for the research of various neurological disorders involving excessive activity of AMPA receptors.
  • Description
    BDZ-g is a potent, selective antagonist of AMPA receptor. BDZ-g has the potential for the research of various neurological disorders involving excessive activity of AMPA receptors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    iGluR
  • Recptor
    iGluR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    732278-52-3
  • Formula Weight
    407.49
  • Molecular Formula
    C21H21N5O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1C=C(C=2C3=C(C=C4C(=C3)OCO4)C[C@@H](C)N(N2)C=5SC(C)=NN5)C=CC1N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wang C, et al. Mechanism and site of inhibition of AMPA receptors: pairing a thiadiazole with a 2,3-benzodiazepine scaffold. ACS Chem Neurosci. 2014;5(2):138-147.?
molnova catalog
related products
  • VPC13566

    (S)-(-)-5-Fluorowillardiine is an AMPA receptor-specific agonist.

  • Dalzanemdor

    Dalzanemdor (SAGE-718) is an NMDA receptor-positive modulator of metabolism that can be used to study Huntington's chorea, Alzheimer's disease, and cognitive dysfunction.

  • CFM-2

    CFM-2, a potent and selective non-competitive antagonist of AMPAR (AMPAR), exhibits anticonvulsant activity across various seizure models.